Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

MDGL Madrigal Pharmaceuticals Inc

243.30

10.14 (4.35%)

Last Updated: 11:24:02

Delayed by 15 minutes

Madrigal shares data from open-label study for its liver disease therapy resmetirom

To read the full story on Seeking Alpha, click here.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Madrigal Pharmaceuticals Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Madrigal Pharmaceuticals Inc News

More Madrigal Pharmaceuticals Inc News Articles

TransCode Therapeutics

Impact Fusion (PK)

Brookmount Explorations (PK)

NaturalShrimp (QB)

Branded Legacy (PK)

RespireRx Pharmaceuticals (CE)

Hannover House (PK)

Valiant Eagle (PK)

Mullen Automotive

ERHC Energy (CE)

Premier Biomedical (PK)

Delayed Upgrade Clock